Gardiner G A
Cardiovascular and Interventional Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107.
Cardiovasc Intervent Radiol. 1988;11 Suppl:S58-9. doi: 10.1007/BF02577098.
Seventy-eight patients with 87 thrombosed grafts or arteries were treated by direct intraarterial infusion of streptokinase or urokinase. Initial success rate in treatment of occluded grafts (60%) was nearly identical to native artery occlusion (63%), and nearly twice as high for urokinase (76%) compared with streptokinase (43%). There was no statistically significant difference in complication rates between native vessel occlusion and thrombosed grafts, or between urokinase- and streptokinase-treated groups. Nineteen of 29 grafts (66%) remain patent after an average 11-month followup.
78例有87处移植血管或动脉血栓形成的患者接受了链激酶或尿激酶直接动脉内输注治疗。移植血管闭塞的初始治疗成功率（60%）与天然动脉闭塞（63%）几乎相同，尿激酶治疗的成功率（76%）几乎是链激酶治疗（43%）的两倍。天然血管闭塞与移植血管血栓形成之间，或尿激酶治疗组与链激酶治疗组之间的并发症发生率无统计学显著差异。29处移植血管中有19处（66%）在平均11个月的随访后仍保持通畅。
